N-Benzoyl-3-phenylisoserine, (2R,3S)-
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
132201-33-3O=C(N[C@@H](c1ccccc1)[C@@H](O)C(=O)O)c1ccccc1HYJVYOWKYPNSTK-UONOGXRCSA-N132201-33-3DTXSID10157433CHEMBL134943安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
使用(2R,3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel (P132500) used to study the location of the binding sites. (2R,3S)-N-Benzoyl-3-phenylisoserine shows cytotoxic, antiviral and immunomodulatory activity.